Literature DB >> 292819

Inosine 5'-phosphate dehydrogenase activity in normal and leukemic blood cells.

H J Becher, G W Löhr.   

Abstract

The enzyme inosinic acid dehydrogenase (EC 1.2.1 [14]) was measured and partially purified (10- to 15-fold) from normal and leukemic leukocytes. From the normal blood cells, the highest activities could be detected in lymphocytes and bone marrow cells. Dependent on the blast cell count, the leukemic IMP dehydrogenase had a higher mean specific activity than the enzymes of fractionated, immature bone marrow cells, or normal granulocytes. The partially purified enzymes from the various blood cells were apparently identical; they exhibited hyperbolic substrate saturation kinetics and were inhibited by a number of purine nucleotides. For the leukemic blast cell enzyme, the Km values for the substrates, IMP and NAD+, were 28 +/- 11; 227 +/- 98 microM, and 34 +/- 10; 240 +/- 67 microM for the partially purified enzyme from normal, immature bone marrow cells. The hypoxanthine-guanine and adenine phosphoribosyltransferase activities increased in the leukemic cells when compared with mature granulocytes, but nearly always showed similar activities when compared with fractionated bone marrow cells. Only one of the 30 investigated leukemic patients exhibited a marked decrease in hypoxanthine phosphoribosyltransferase activity of 0.5 nmol/mg/h. The phosphoribosyltransferase-specific activities of the leukemic cells are more variable than for the normal ones and no correlation of enzyme activities and blast cell count was apparent.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 292819     DOI: 10.1007/bf01481491

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  33 in total

1.  INHIBITION OF INOSINE 5'-PHOSPHATE DEHYDROGENASE FROM EHRLICH ASCITES-TUMOUR CELLS BY 6-THIONINOSINE 5'-PHOSPHATE.

Authors:  M R ATKINSON; R K MORTON; A W MURRAY
Journal:  Biochem J       Date:  1963-10       Impact factor: 3.857

2.  Hypoxanthine phosphoribosyltransferase activity in normal, developing, and neoplastic tissues of the rat.

Authors:  R M Wohlhueter
Journal:  Eur J Cancer       Date:  1975-07       Impact factor: 9.162

3.  Inosine 5'-monophosphate dehydrogenase from sarcoma 180 cells-substrate and inhibitor specificity.

Authors:  R L Miller; D L Adamczyk
Journal:  Biochem Pharmacol       Date:  1976-04-15       Impact factor: 5.858

4.  Inosinic acid dehydrogenase in mammalian tissues.

Authors:  P A Saccoccia; R P Miech
Journal:  Mol Pharmacol       Date:  1969-01       Impact factor: 4.436

5.  Inosinic acid dehydrogenase of sarcoma 180 cells.

Authors:  J H Anderson; A C Sartorelli
Journal:  J Biol Chem       Date:  1968-09-25       Impact factor: 5.157

6.  Leukocyte purine phosphoribosyltransferases in human leukemias sensitive and resistant to 6-thiopurines.

Authors:  M Rosman; H E Williams
Journal:  Cancer Res       Date:  1973-06       Impact factor: 12.701

7.  IMP: and AMP:pyrophosphate phosphoribosyltransferase in leukemic and normal human leukocytes.

Authors:  J L Smith; G A Omura; I H Krakoff; M E Balis
Journal:  Proc Soc Exp Biol Med       Date:  1971-04

Review 8.  Enzymology of cancer cells (first of two parts).

Authors:  G Weber
Journal:  N Engl J Med       Date:  1977-03-03       Impact factor: 91.245

Review 9.  Synthesis and metabolism of DNA and DNA precursors by human normal and leukemic leukocytes. A summary of recent information.

Authors:  R C Gallo
Journal:  Acta Haematol       Date:  1971       Impact factor: 2.195

10.  Purine nucleotide synthesis in normal and leukemic blood cells.

Authors:  H Becher; M Weber; G W Löhr
Journal:  Klin Wochenschr       Date:  1978-03-15
View more
  6 in total

1.  Effect of helenalin and bis(helenalinyl)malonate on nucleic acid and protein synthesis in human KB carcinoma cells.

Authors:  I H Hall; A A Grippo; K H Lee; S G Chaney; D J Holbrook
Journal:  Pharm Res       Date:  1987-12       Impact factor: 4.200

2.  Enhanced purine nucleotide synthesis in erythrocytes of uremic patients.

Authors:  H J Becher; H J Weise; U Volkermann; P Schollmeyer
Journal:  Klin Wochenschr       Date:  1980-11-17

3.  Inhibition of salvage pathway enzymes by adenine arabinoside 5'-monophosphate (ara-AMP).

Authors:  H J Becher; P Schollmeyer
Journal:  Klin Wochenschr       Date:  1983-08-01

4.  The effects of boron containing peptides on L1210 lymphoid leukemia metabolism.

Authors:  I H Hall; E S Hall; M C Miller; A Sood; B F Spielvogel
Journal:  Amino Acids       Date:  1993-10       Impact factor: 3.520

5.  Purine metabolism in myeloid precursor cells during maturation. Studies with the HL-60 cell line.

Authors:  D L Lucas; H K Webster; D G Wright
Journal:  J Clin Invest       Date:  1983-12       Impact factor: 14.808

6.  Cytotoxicity of boron containing dipeptide analogs.

Authors:  S Karthikeyan; A Sood; J Tomasz; B F Spielvogel; I H Hall
Journal:  Amino Acids       Date:  1995-12       Impact factor: 3.520

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.